Diagnostic predictive value of the Bladder EpiCheck test in the follow‐up of patients with non–muscle‐invasive bladder cancer

Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer

(2018) Carolina D´Elia et al.   JOURNAL OF CLINICAL PATHOLOGY

MP13-15 MOLECULAR URINE CYTOLOGY – BLADDER EPICHECK IS A NOVEL MOLECULAR DIAGNOSTIC TOOL FOR MONITORING OF BLADDER CANCER PATIENTS

(2016) Adam Wasserstrom et al.   JOURNAL OF UROLOGY

Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer

(2014) Willemien Beukers et al.   MODERN PATHOLOGY

Urine markers for detection and surveillance of bladder cancer

(2013) Evanguelos Xylinas et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

(2011) Derya Tilki et al.   EUROPEAN UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

UroVysion FISH test for detecting urothelial cancers: Meta-analysis of diagnostic accuracy and comparison with urinary cytology testing

(2008) Tine Hajdinjak   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS